← Back to Clinical Trials
Recruiting NCT06150690

NCT06150690 Study on Pancreatic Islets in Patients Undergoing (Partial) Pancreatectomy (PRECISE)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06150690
Status Recruiting
Phase —
Sponsor German Diabetes Center
Condition Diabetes Mellitus
Study Type OBSERVATIONAL
Enrollment 400 participants
Start Date 2012-08-21
Primary Completion 2030-12-31

Trial Parameters

Condition Diabetes Mellitus
Sponsor German Diabetes Center
Study Type OBSERVATIONAL
Phase N/A
Enrollment 400
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2012-08-21
Completion 2030-12-31
Interventions
No intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The study investigates the mechanisms underlying the pathogenesis of diabetes by examining structural and functional properties of islets of Langerhans in pancreas specimen from patients undergoing (partial) pancreatectomy.

Eligibility Criteria

Inclusion Criteria: ability to give informed consent Exclusion Criteria: denial of informed consent

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

VIEW ON CLINICALTRIALS.GOV ↗ MORE DIABETES MELLITUS TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology